- Filed
- Mar 3, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2023 · Feb 24, 2025 | 104 sh |
| Shares Diluted | FY 2023 · Dec 31, 2022 | 9.21M sh |
| Capex restated | FY 2023 · Dec 31, 2022 | $10.28K |
| Operating Cash Flow restated | FY 2023 · Dec 31, 2022 | −$2M |
| Cash And Equivalents restated | FY 2023 · Dec 31, 2022 | $22.81K |
| Current Liabilities restated | FY 2023 · Dec 31, 2022 | $384.59K |
| Total Liabilities restated | FY 2023 · Dec 31, 2022 | $1.41M |
| Current Assets restated | FY 2023 · Dec 31, 2022 | $30.18K |
| Total Assets restated | FY 2023 · Dec 31, 2022 | $160.56K |
| Eps Diluted | FY 2023 · Dec 31, 2022 | −$0.41 |
| Eps Basic | FY 2023 · Dec 31, 2022 | −$0.41 |
| Sga Expense restated | FY 2023 · Dec 31, 2022 | $1.14M |
| Net Income restated | FY 2023 · Dec 31, 2022 | −$3.78M |
| Operating Income restated | FY 2023 · Dec 31, 2022 | −$3.73M |
| Gross Profit restated | FY 2023 · Dec 31, 2022 | $416.86K |
| Cost Of Revenue restated | FY 2023 · Dec 31, 2022 | $765.89K |
| Revenue restated | FY 2023 · Dec 31, 2022 | $1.18M |
| Stockholders Equity restated | FY 2023 · Dec 31, 2021 | −$455.79K |